Schrodinger, Inc. (SDGR)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 255,869,000 23.3%
- Net income
- -103,265,000
- Gross profit
- 142,614,000
- Operating income
- -166,896,000
- Earnings per share
- -1.41
- R&D expense
- 173,138,000
Growth and profitability
- Gross margin
- 55.74
- Operating margin
- -65.23
- Net margin
- -40.36
- Return on equity
- -28.37
- Return on assets
- -14.22
- Free cash flow margin
- 4.87
Balance sheet
- Total assets
- 726,160,000
- Total liabilities
- 362,107,000
- Shareholders' equity
- 364,053,000
- Cash and equivalents
- 230,517,000
- Current ratio
- 2.75
Cash flow and ratios
- Operating cash flow
- 13,899,000
- Free cash flow
- 12,457,000
Company information
- Headquarters
- New York, NY
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
Schrodinger, Inc. trades on NASDAQ under the ticker symbol SDGR. This page brings together its price chart, company profile, key financial figures and technical indicators.